Advertisements



Medtronic initiates clinical study to assess safety of drug-eluting stents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Emergent BioSolutions initiates Phase 1 clinical study of anti-Zika drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2018

BioLineRx initiates Phase 1/2a clinical study for AGI-134

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

J&J"s (JNJ) Phase III Study for Invokana Halted Earlier

Johnson & Johnson's (JNJ) phase III CREDENCE study evaluating the efficacy and safety of its diabetes drug Invokana is being stopped early based on positive pre-specified efficacy data. Johnson & Johnson JNJ .....»»

Category: personnelSource: nytJul 17th, 2018

Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

CohBar initiates clinical study with first-in-human dosing of CB4211

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Advaxis initiates IND with FDA to study first ADXS-HOT drug candidate for NSCLC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Viveve submits VIVEVE II clinical study patient safety data to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 3rd, 2018

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Zacks.....»»

Category: topSource: redinewsJun 20th, 2018

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Agios Pharmaceuticals, Inc. (AGIO), initiates a phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with PK deficiency w.....»»

Category: dealsSource: nytJun 20th, 2018

Inovio Initiates Phase II Study on Pipeline Drug VGX-3100

Inovio (INO) begins a phase II study to evaluate the efficacy of its pipeline candidate VGX-3100 on adult men and women with human papilloma virus (HPV)-related anal dysplasia. Inovio Pharmaceuticals, INO has initiated a .....»»

Category: dealsSource: nytMay 22nd, 2018

Nektar initiates Phase 1b clinical study of NKTR-358

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 8th, 2018

Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis. Catalyst Pharmaceuticals, Inc. CPRX, enroled.....»»

Category: worldSource: nytApr 20th, 2018

Epizyme (EPZM) Publishes Tazemetostat Phase I Data, Stock Up

Epizyme (EPZM) publishes tazemetostat phase I clinical data in The Lancet Oncology. The study demonstrated favorable safety findings and anti-tumor activity. Shares of .....»»

Category: dealsSource: nytApr 11th, 2018

Mateon Therapeutics receives notice of partial clinical hold for OX1222 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 17th, 2018

Glaxo, J&J"s Dual Drug HIV Regimen Succeeds in Phase III Study

Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV. GlaxoSmithKline’s GSK HIV drug subsidiary-ViiV H.....»»

Category: smallbizSource: nytAug 17th, 2018

Inovio Pharmaceuticals Initiates Dosing in HIV Vaccine Study

Inovio Pharmaceuticals (INO) doses the first patient in a phase I/II study, which will evaluate its HIV vaccine Pennvax-GP's abil.....»»

Category: dealsSource: nytAug 16th, 2018

ICC creates new committee on building safety and security

The International Code Council Board of Directors has established an ad hoc committee to explore and assess building safety and security......»»

Category: realestateSource: bdcnetworkAug 15th, 2018

30 Stocks Moving In Wednesday"s Pre-Market Session

Gainers Oragenics Inc (NYSE: OGEN) rose 27.2 percent to $0.63 in pre-market trading after the company disclosed that it has resumed Phase 2 clinical trial of AG013 in oral mucositis following positive routine safety review. read more.....»»

Category: blogSource: benzingaAug 15th, 2018

Electromed "thrilled" by results of independent clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2018